Amrutanjan Health Care Share Price
Start SIP in Amrutanjan Health Care
Start SIPAmrutanjan Health Care Performance
Day Range
- Low 775
- High 791
52 Week Range
- Low 564
- High 863
- Open Price789
- Previous Close785
- Volume21664
Amrutanjan Health Care Investment Rating
-
Master Rating:
-
Amrutanjan Health Care has an operating revenue of Rs. 427.10 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 15% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 84 | 127 | 117 | 99 | 78 | 100 |
Operating Expenses Qtr Cr | 80 | 111 | 95 | 92 | 71 | 87 |
Operating Profit Qtr Cr | 4 | 16 | 22 | 7 | 7 | 13 |
Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 1 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 2 | 6 | 6 | 2 | 2 | 4 |
Net Profit Qtr Cr | 5 | 14 | 17 | 7 | 7 | 13 |
Amrutanjan Health Care Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹792.02
- 50 Day
- ₹774.09
- 100 Day
- ₹747.12
- 200 Day
- ₹711.43
- 20 Day
- ₹796.56
- 50 Day
- ₹771.70
- 100 Day
- ₹752.55
- 200 Day
- ₹685.07
Amrutanjan Health Care Resistance and Support
Resistance | |
---|---|
First Resistance | 793.83 |
Second Resistance | 800.32 |
Third Resistance | 809.73 |
RSI | 49.91 |
MFI | 74.39 |
MACD Single Line | 11.83 |
MACD | 7.74 |
Support | |
---|---|
First Support | 777.93 |
Second Support | 768.52 |
Third Supoort | 762.03 |
Amrutanjan Health Care Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 24,502 | 1,237,106 | 50.49 |
Week | 26,324 | 1,327,772 | 50.44 |
1 Month | 131,962 | 5,401,211 | 40.93 |
6 Month | 79,067 | 3,639,447 | 46.03 |
Amrutanjan Health Care Result Highlights
Amrutanjan Health Care Synopsis
NSE-Medical-Generic Drugs
Amrutanjan Health Ca is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 421.23 Cr. and Equity Capital is Rs. 2.89 Cr. for the Year ended 31/03/2024. Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017.Market Cap | 2,269 |
Sales | 427 |
Shares in Float | 1.42 |
No of funds | 31 |
Yield | 0.59 |
Book Value | 7.87 |
U/D Vol ratio | 1.5 |
LTDebt / Equity | |
Alpha | 0.04 |
Beta | 0.65 |
Amrutanjan Health Care Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 50.59% | 50.59% | 50.59% | 50.59% |
Mutual Funds | 6.76% | 6.79% | 6.79% | 6.79% |
Foreign Portfolio Investors | 1.55% | 1.38% | 0.8% | 0.75% |
Financial Institutions/ Banks | 0.09% | 0.09% | 0.09% | 0.09% |
Individual Investors | 33.87% | 34.16% | 34.61% | 34.99% |
Others | 7.14% | 6.99% | 7.12% | 6.79% |
Amrutanjan Health Care Management
Name | Designation |
---|---|
Mr. S Sambhu Prasad | Chairman & Managing Director |
Dr. Pasumarthi S N Murthi | Non Executive Director |
Mr. G Raghavan | Ind. Non-Executive Director |
Ms. Ramaa Prabhakar Arikirevula | Non Executive Director |
Ms. Meenalochani Raghunathan | Ind. Non-Executive Director |
Mr. Raja Venkataraman | Ind. Non-Executive Director |
Mr. S Muralidharan | Ind. Non-Executive Director |
Amrutanjan Health Care Forecast
Price Estimates
Amrutanjan Health Care Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-08-13 | Quarterly Results | |
2024-05-23 | Audited Results & Final Dividend | |
2024-02-09 | Quarterly Results & Interim Dividend | |
2023-11-10 | Quarterly Results & Interim Dividend | |
2023-08-02 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-20 | INTERIM | Rs.1.00 per share(100%)Second Interim Dividend |
2023-11-23 | INTERIM | Rs.1.00 per share(100%)Interim Dividend |
2023-09-14 | FINAL | Rs.2.60 per share(260%)Final Dividend |
2023-02-24 | INTERIM | Rs.1.00 per share (100%) Second Interim Dividend |
2022-11-15 | INTERIM | Rs.1.00 per share(100%)First Interim Dividend |
Amrutanjan Health Care FAQs
What is Share Price of Amrutanjan Health Care ?
Amrutanjan Health Care share price is ₹787 As on 14 September, 2024 | 01:36
What is the Market Cap of Amrutanjan Health Care ?
The Market Cap of Amrutanjan Health Care is ₹2276.3 Cr As on 14 September, 2024 | 01:36
What is the P/E ratio of Amrutanjan Health Care ?
The P/E ratio of Amrutanjan Health Care is 53.5 As on 14 September, 2024 | 01:36
What is the PB ratio of Amrutanjan Health Care ?
The PB ratio of Amrutanjan Health Care is 7.9 As on 14 September, 2024 | 01:36